Results 131 to 140 of about 56,454 (256)

Herbal Therapeutics in Osteoporosis: Mechanisms, Evidence, and Translational Potential

Phytotherapy Research, EarlyView.
Schematic overview of bone remodeling dysregulation in osteoporosis and the multi‐target protective role of herbal therapeutics. ABSTRACT Osteoporosis is a chronic bone disease marked by reduced density and increased fracture risk. Current treatments face limitations in safety, efficacy, and long‐term adherence, prompting interest in alternative ...
Elnaz Vafadar Moradi, Sina Vossoughinia, Zahra Yazdanpanah, Hossein Sobhani, Jalileh Jalali, Mahboobeh Ghasemzadeh Rahbardar   +5 more
wiley   +1 more source

Adjuvant treatment of gastrointestinal stromal tumors (GIST)-state of the art, controversies, and future directions. [PDF]

ESMO Gastrointest Oncol
Scheuble AM, Lordick F, Maki RG.
europepmc   +1 more source

Potential of Ginkgo biloba Extract to Intervene in Chronic Inflammation‐Related Diseases

Phytotherapy Research, EarlyView.
Chronic inflammation is a pathological mechanism underpinning many diseases. Ginkgo biloba extract (GBE) is well known for its anti‐inflammatory property. GBE and its active constituents have been shown to attenuate pro‐inflammatory cytokine production, suppress nuclear factor kappa B activation, restore redox homeostasis, and modulate disease‐relevant
Yipeng Lin, Inho Cho, Xue Zhu, Ke Wang, Ling Zhu, Wenchang Wong, Michael Murray, Fanfan Zhou   +7 more
wiley   +1 more source

Bite-on-Bite Near Miss: From Hemangioma to Gastrointestinal Stromal Tumors. [PDF]

ACG Case Rep J
Reszczynski O, Zaver HB, Patel D, Farid C, Powell S, Strand DS.   +5 more
europepmc   +1 more source

A Recurrent Tympanicum Paraganglioma With a SDHD Pathogenic Variant: Fourth Reported Case

World Journal of Otorhinolaryngology - Head and Neck Surgery, EarlyView.
ABSTRACT Objective The aim of this study is to describe a clinical case of a SDHD germline mutation associated tympanic paraganglioma (TPGL). Patients A female patient seen in the otology clinic at a tertiary care center with a diagnosis of tympanic paraganglioma and significant family history of head and neck paragangliomas.
Alex Z. Graboyes, Kevin Wong, Yonghong Huan, Jason A. Brant   +3 more
wiley   +1 more source

Identifying actionable targets: predicting imatinib nonadherence in patients with gastrointestinal stromal tumors. [PDF]

J Gastrointest Oncol
Janczewski LM.
europepmc   +1 more source

Hemorrhagic Gastrointestinal Stromal Tumor

ACG Case Reports Journal, 2022
Perez Del Nogal, Genesis, Gopal, Purva, Okwara, Chinemerem   +2 more
openaire   +2 more sources

Safety and Efficacy of Deucravacitinib in Japanese Patients With Moderate to Severe Plaque Psoriasis: 5‐Year Analysis of the Phase 3 POETYK PSO‐1, PSO‐4, and Long‐Term Extension Trials

The Journal of Dermatology, EarlyView.
ABSTRACT Deucravacitinib, an oral, selective tyrosine kinase 2 inhibitor, is approved in multiple countries for the treatment of moderate to severe plaque psoriasis, as well as generalized pustular and erythrodermic psoriasis in Japan. Deucravacitinib 6 mg once daily was efficacious and well tolerated through 3 years in the pooled population of ...
Yukari Okubo, Akimichi Morita, Yayoi Tada, Shinichi Imafuku, April W. Armstrong, Andrew Blauvelt, John Vaile, Zoran Popmihajlov, Janice Li, Rajesh Sawant, Katsuyoshi Habiro, Katsuki Tsuritani, Mamitaro Ohtsuki   +12 more
wiley   +1 more source

Deep Learning Predicts Mutations and Outcomes in Gastrointestinal Stromal Tumors. [PDF]

Cancer Res
Bonetti A, Le VL, Carrero ZI, Wolf F, Gustav M, Lam SW, Vanhersecke L, Sobczuk P, Le Loarer F, Lenarcik M, Rutkowski P, van Sabben JM, Steeghs N, Van Boven HH, Machado I, Bagué S, Navarro S, Medina-Ceballos E, Agra-Pujol C, Giner F, Tapia G, Hernández-Gallego A, Civantos-Jubera G, Cuatrecasas M, Lopez-Prades S, Perret R, Soubeyran I, Khalifa E, Blouin L, Wardelmann E, Meurgey A, Collini P, Voloshin A, Yatabe Y, Hirano H, Gronchi A, Nishida T, Bouche O, Emile JF, Ngo C, Hohenberger P, Cotarelo C, Jakob J, Bovee JVMG, Gelderblom H, Szumera-Ciećkiewicz A, Jean-Denis M, Bollard J, Lassau N, Le Cesne A, Blay JY, Italiano A, Crombe A, Coindre JM, Kather JN.   +54 more
europepmc   +1 more source

Systemic Therapy Management Strategies for Early‐Stage Breast Cancer in Australia

Asia-Pacific Journal of Clinical Oncology, EarlyView.
Advances in systemic therapy for early‐stage breast cancer in Australia highlight genomic‐guided decisions, subtype‐specific strategies, and emerging targeted and immunotherapies, shaping personalized and de‐escalated treatment approaches. ABSTRACT Breast cancer is the most common cancer among Australian women, with early‐stage disease (Stages I, II ...
Nicholas Zdenkowski, Rachel Dear, Sanjeev Kumar, Hilary Martin, Dhanusha Sabanathan, Stephen J. Luen, Belinda Yeo   +6 more
wiley   +1 more source